Jennison Associates
UTHR icon

Jennison Associates’s United Therapeutics UTHR Stock Holding History

Jennison Associates’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,736
Closed -$6.6M – 630
2022
Q4 		$6.6M Buy
23,736
+21,645
+1,035% +$5.46M 0.01% 417
2022
Q3 		$438K Sell
2,091
-6,336
-75% -$1.42M ﹤0.01% 590
2022
Q2 		$1.99M Buy
+8,427
New +$1.71M ﹤0.01% 462
2014
Q1 		– Sell
-15,087
Closed -$1.71M – 785
2013
Q4 		$1.71M Sell
15,087
-1,040
-6% -$93.8K ﹤0.01% 573
2013
Q3 		$1.27M Buy
16,127
+334
+2% +$24.4K ﹤0.01% 591
2013
Q2 		$1.04M Buy
+15,793
New +$1.02M ﹤0.01% 586

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return